Treatment and outcome of parosteal osteosarcoma: Biological versus endoprosthetic reconstruction

2011 ◽  
Vol 103 (8) ◽  
pp. 782-789 ◽  
Author(s):  
Philipp T. Funovics ◽  
Frederik Bucher ◽  
Cyril D. Toma ◽  
Rainer I. Kotz ◽  
Martin Dominkus
2021 ◽  
pp. 983-988
Author(s):  
Daniel Cirotski ◽  
Jyoti Panicker

Osteosarcoma is the most common primary bone cancer in all age groups. Metastasis mostly occurs with high-grade tumors disseminating to the lungs and other bones. Spread to the pancreas is rare and undocumented in the low-grade subtypes. Additionally, it is uncommon for the disease course of low-grade subtypes to involve multiple relapses. We present a 35-year-old woman with parosteal osteosarcoma who has experienced an atypical metastasis to the pancreas as well as multiple local and pulmonary relapses. The lesion was identified incidentally on routine imaging, and the patient underwent resection. We compare our case to the other reports of pancreatic metastasis in the literature. Despite being especially rare, clinicians ought to be aware of pancreatic metastasis of osteosarcoma. Furthermore, despite parosteal osteosarcoma’s less aggressive disease course, it can uncommonly lead to multiple relapses. We present a rare case exemplifying these phenomena in the prognostically favorable histologic subtype of parosteal osteosarcoma.


2010 ◽  
Vol 16 (2) ◽  
pp. 95
Author(s):  
Chang Ho Kang ◽  
Jong Hoon Park ◽  
Dae Hee Lee ◽  
Chul Hwan Kim ◽  
Jeong Mi Park ◽  
...  

2015 ◽  
Vol 97 (22) ◽  
pp. e72 ◽  
Author(s):  
Annie Arteau ◽  
Valerae O. Lewis ◽  
Bryan S. Moon ◽  
Robert L. Satcher ◽  
Justin E. Bird ◽  
...  

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Christoph Böhler ◽  
Stephan Brönimann ◽  
Alexandra Kaider ◽  
Stephan E. Puchner ◽  
Irene K. Sigmund ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-5
Author(s):  
Hironari Tamiya ◽  
Hiroki Hagizawa ◽  
Takaaki Nakai ◽  
Yoshinori Imura ◽  
Takaaki Tanaka ◽  
...  

Zoledronate or denosumab treatment is beneficial for cancer patients with bone metastasis. However, each agent may trigger atypical femoral fractures. Incomplete atypical femoral fractures can be successfully treated with prophylactic intramedullary nailing. On the other hand, intramedullary nailing for displaced atypical femoral fractures occasionally causes problems with regard to bone healing, resulting in long-term treatment. In cancer patients with poor prognosis who experience atypical femoral fractures, improvement in activities of daily living should be the priority. Thus, we performed endoprosthetic reconstruction for a displaced atypical femoral fracture in a breast cancer patient with poor prognosis to enable walking in the early stage after the operation. Two weeks after the operation, she could successfully walk. The postoperative Musculoskeletal Tumor Society score was 47%, and it had improved to almost the preoperative level before injury (50%). In conclusion, endoprosthetic reconstruction for displaced atypical femoral fractures may be a first-line treatment approach to acquire early postoperative walking ability for improving activities of daily living in cancer patients with poor prognosis.


The Knee ◽  
2018 ◽  
Vol 25 (5) ◽  
pp. 952-958
Author(s):  
Fangzhou He ◽  
Chuanzhen Hu ◽  
Yuhui Shen ◽  
Qiyuan Bao ◽  
Junxiang Wen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document